Literature DB >> 3100964

Stimulation of specific GTP binding and hydrolysis activities in lymphocyte membrane by interleukin-2.

S W Evans, S K Beckner, W L Farrar.   

Abstract

Interleukin-2 (IL-2) is a polypeptide growth factor which stimulates the proliferation and differentiation of T lymphocytes. The receptor for IL-2 is expressed on activated T lymphocytes, cloned IL-2 dependent cells and several other cell types. Analysis of the primary structure and of immune-precipitated receptor suggests that this molecule has no intrinsic signal transduction function, unlike other growth factors. IL-2 interaction with a high affinity receptor has been shown, however, to activate the calcium/phospholipid-dependent protein kinase C (PK-C) presumably via phosphoinositide hydrolysis. Members of a family of closely related guanine nucleotide binding proteins (G proteins) regulate a diverse group of metabolic events. Two of them, Gs and Gi, stimulate and inhibit adenylate cyclase activity respectively, and other G proteins are involved in diverse signal transduction system. Another member, Go, has no known function and activation of phospholipase C has been attributed to the action of an unidentified G protein, Gp. Since it has been observed that IL-2 inhibits the catalytic activity of adenylate cyclase and that agents such as PGE2 which stimulate adenylate cyclase activity inhibit the lymphoproliferative response to IL-2, association of GTP binding proteins with IL-2 signal transduction was investigated. In this report we describe for the first time the participation of a GTP binding protein in the action of a polypeptide growth factor, interleukin-2.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100964     DOI: 10.1038/325166a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  14 in total

Review 1.  Cytokine receptors: structure and signal transduction.

Authors:  B M Foxwell; K Barrett; M Feldmann
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  Photoaffinity labeling of ATP and NAD+ binding sites on recombinant human interleukin 2.

Authors:  S Campbell; H Kim; M Doukas; B Haley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Interleukin-2 lengthens extrajunctional acetylcholine receptor channel open time in mammalian muscle cells.

Authors:  P Lorenzon; F Ruzzier; C G Caratsch; A Giovannelli; F Velotti; A Santoni; F Eusebi
Journal:  Pflugers Arch       Date:  1991-10       Impact factor: 3.657

4.  Transforming growth factor beta 1 treatment of AKR-2B cells is coupled through a pertussis-toxin-sensitive G-protein(s).

Authors:  P H Howe; E B Leof
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

Review 5.  Protein kinase C in IL-2 signal transduction.

Authors:  Y Lu; J P Durkin
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

6.  Reduction of the acetylcholine-induced K+ current in identified Aplysia neurons by human interleukin-1 and interleukin-2.

Authors:  M Sawada; N Hara; T Maeno
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

7.  Inhibition of the calcitonin-induced outward current in identified Aplysia neurons by interleukin-1 and interleukin-2.

Authors:  M Sawada; M Ichinose; G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1994-04       Impact factor: 5.046

8.  Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils.

Authors:  Y H Atkinson; W A Marasco; A F Lopez; M A Vadas
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

9.  Cholera toxin inhibits interleukin-2-induced, but enhances pertussis toxin-induced T-cell proliferation: regulation by cyclic nucleotides.

Authors:  A A Maghazachi
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

10.  Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders.

Authors:  K Alonso; R Medenica
Journal:  J Natl Med Assoc       Date:  1995-08       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.